Reviewed by
Brandon Johnson — Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant
Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness. He reviews all PSPeptides educational content for scientific accuracy and practical relevance.
The GHRP-2 peptide (Growth Hormone Releasing Peptide-2), also known as pralmorelin, is the most potent growth hormone secretagogue in the GHRP family — producing stronger GH pulses per microgram than GHRP-6, Hexarelin, or Ipamorelin. First developed as a diagnostic tool for growth hormone deficiency, the GHRP-2 peptide has become a reference compound for understanding how synthetic ghrelin mimetics drive pulsatile GH release from the anterior pituitary. It holds a distinction no other GHRP can claim: regulatory approval in Japan as pralmorelin for the diagnosis of growth hormone deficiency — making it the only GHRP with any governmental approval worldwide.
PSPeptides now offers research-grade GHRP-2 at 99%+ HPLC-verified purity with batch-specific COAs, free shipping, and same-day processing including Sundays. This guide covers the GHRP-2 peptide mechanism, GH release potency data, published research, dosing protocols, side effect profile, and how it compares to other growth hormone secretagogues in the PSPeptides catalog.
How the GHRP-2 Peptide Works: Mechanism of Action
Pralmorelin (sequence: D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH₂) is a synthetic hexapeptide that binds to and activates the growth hormone secretagogue receptor type 1a (GHS-R1a) — the same receptor targeted by the body’s endogenous hunger hormone, ghrelin. Upon binding GHS-R1a on pituitary somatotroph cells, pralmorelin activates the Gq/11 → PLC → IP₃/DAG → intracellular calcium → PKC signaling cascade, triggering growth hormone vesicle exocytosis — a direct, potent GH pulse.
This mechanism is fundamentally different from how GHRH analogs like CJC-1295 and Sermorelin work (GHRHR → Gs → cAMP → PKA pathway). This mechanistic distinction is why combining GHRP-2 with a GHRH analog produces synergistic GH release — the two pathways converge on different second-messenger systems in the same somatotroph cell, producing amplified GH output that neither compound achieves alone. The CJC-1295/Ipamorelin guide covers the GHRH pathway in detail.
Beyond pituitary action, the GHRP-2 peptide also acts centrally — stimulating hypothalamic GHRH neurons and antagonizing somatostatin tone, further amplifying GH release. Published research documents that the GHRP-2 peptide produces the highest peak GH concentration among commonly used GHRPs, with moderate effects on cortisol, prolactin, and appetite. This places GHRP-2 between the highly selective Ipamorelin (minimal side effects, moderate GH) and the non-selective GHRP-6 (strong side effects, strong GH) in the selectivity spectrum.
GHRP-2 Growth Hormone Release Potency
The landmark Arvat et al. (1997) study — the definitive head-to-head pharmacological characterization of the GHRP class — established that the GHRP-2 peptide produces the strongest acute GH pulse among the standard GHRPs at equivalent doses. Published research documents peak GH concentrations of approximately 40-60 ng/mL following administration at standard research doses, compared to 25-40 ng/mL for GHRP-6 and 20-35 ng/mL for Ipamorelin at equivalent doses (individual response varies significantly).
This GH potency advantage is the primary reason researchers choose the GHRP-2 peptide over other secretagogues. When the research question requires maximum GH amplitude — for studying IGF-1 elevation, body composition effects, or recovery parameters — the GHRP-2 peptide provides the strongest signal. When the research question requires cleaner GH release without cortisol or prolactin interference, Ipamorelin is preferred. The muscle growth peptide guide covers the broader GH-muscle connection.
Pralmorelin Regulatory Status and Approvals
This compound holds a unique regulatory distinction: it is approved in Japan under the name pralmorelin for the GHRP-2 stimulation test, a diagnostic procedure for evaluating growth hormone deficiency. The pralmorelin stimulation test has been validated as an alternative to the insulin tolerance test (ITT) for HPA axis evaluation — a clinically significant validation that confirms pralmorelin’s pharmacological activity in human subjects under regulatory scrutiny.
This Japanese regulatory approval means pralmorelin has undergone formal safety and efficacy evaluation by a national drug regulatory authority — a level of validation that no other GHRP (including Ipamorelin and GHRP-6) has achieved. For researchers, this regulatory history provides the most robust safety characterization available for any GH secretagogue peptide. GHRP-2 is sold by PSPeptides for research use only and is not FDA-approved for therapeutic use in the United States.
GHRP-2 Peptide Research Dosing Protocols
Published research protocols for GHRP-2 typically use 100-300mcg administered subcutaneously on an empty stomach (30-60 minutes before eating or 2+ hours after meals). Elevated blood glucose and free fatty acids significantly blunt the GH response, making fasted administration essential. Common research timing: morning fasted and/or before bed (aligning with the natural nocturnal GH pulse).
| Protocol | GHRP-2 Peptide Dose | Frequency | Timing | Notes |
|---|---|---|---|---|
| Standard | 100-200mcg | 2-3x daily | Fasted (AM + pre-bed) | Most common research protocol |
| Maximum GH | 200-300mcg | 3x daily | AM + pre-workout + pre-bed | Higher cortisol/prolactin risk |
| Synergy stack | 100mcg + CJC-1295 | 2x daily | Fasted | GHRP + GHRH = synergistic GH |
The free PSPeptides reconstitution calculator provides exact syringe units for any GHRP-2 dose. For a 5mg vial reconstituted with 2mL bacteriostatic water: concentration = 2.5mg/mL. A 200mcg (0.2mg) dose = 8 units on a U-100 syringe. The reconstitution guide covers preparation technique.
Side Effect Profile of GHRP-2
The GHRP-2 peptide side effect profile reflects its moderate selectivity — positioned between the clean Ipamorelin and the non-selective GHRP-6. Published research documents: moderate cortisol elevation (dose-dependent, generally within physiological range at standard doses), moderate prolactin elevation (typically transient), mild appetite stimulation (less intense than GHRP-6), and potential water retention at higher doses. The peptide side effects guide covers broader safety considerations.
GHRP-2 in the PSPeptides GH Secretagogue Catalog
The GHRP-2 peptide at PSPeptides joins the most comprehensive growth hormone secretagogue lineup available from any single vendor. GHRP-6 for appetite-stimulating GH research. Ipamorelin ($39.99) for selective, clean GH release. CJC-1295/Ipamorelin Blend ($65.99) for synergistic GHRH+GHRP research. CJC-1295 No DAC ($35.99) for GHRH-only protocols. Sermorelin ($44.99-$79.99) for the established GHRH analog. All at 99%+ HPLC-verified purity with batch-specific COAs, free shipping, same-day processing including Sundays, and Affirm/Afterpay at zero fees.
GHRP-2 provides the maximum GH amplitude option in this lineup — the compound researchers choose when potency is the priority and moderate side effects are acceptable. 24/7 support via live chat, email ([email protected]), and phone/text at (551) 284-2670 is available for any questions about GHRP-2 or its stacking with other GH compounds. PubMed indexes the GHRP-2 peptide research literature. Wikipedia covers GHRP-2/pralmorelin’s pharmacology. The peptide stacking guide covers GHRP + GHRH combination protocols.
GHRP-2 Synergy With GHRH Analogs
The GHRP-2 peptide’s GH-releasing mechanism operates through the Gq/PLC/calcium pathway — fundamentally different from how GHRH analogs (CJC-1295, Sermorelin) work through the Gs/cAMP/PKA pathway. When the GHRP-2 peptide is administered alongside a GHRH analog, the two pathways converge on the same pituitary somatotroph cell through different second-messenger systems, producing synergistic GH release that exceeds the sum of either compound alone. The landmark Veldhuis et al. (2009) study demonstrated this synergy quantitatively.
PSPeptides carries the complete GHRH analog lineup for GHRP-2 stacking: CJC-1295/Ipamorelin Blend ($65.99), CJC-1295 No DAC ($35.99), and Sermorelin ($44.99-$79.99). The most common synergy protocol: 100mcg GHRP-2 combined with 100mcg CJC-1295 No DAC, administered subcutaneously on an empty stomach 2-3 times daily. This combination produces GH pulses significantly larger than either GHRP-2 or CJC-1295 alone — the foundational principle of every modern GH secretagogue research protocol.
Research Applications Beyond GH Release
While this compound is primarily studied for GH secretion, published research documents additional effects through GHS-R1a activation. The GHRP-2 peptide stimulates hypothalamic GHRH neurons while simultaneously suppressing somatostatin tone — a dual central action that amplifies GH release beyond what pituitary-level stimulation alone produces. The GHRP-2 stimulation test (validated in Japan as the pralmorelin test) has been established as a clinical tool for evaluating HPA axis function, demonstrating that the GHRP-2 peptide’s cortisol-stimulating effects are reliable enough for diagnostic use.
Published research also documents effects on sleep architecture — GH secretagogues administered before bed augment the natural nocturnal GH pulse, which may enhance the sleep-dependent recovery processes that GH mediates. For researchers studying the GH-sleep-recovery axis, the GHRP-2 peptide provides the strongest GH stimulus available in a GHRP format. The peptides for sleep and recovery guide covers the sleep peptide research landscape.
Reconstitution and Practical Research Guidance
Preparing the GHRP-2 peptide for research follows the standard lyophilized peptide protocol. Reconstitute with bacteriostatic water ($19.99 at PSPeptides) — typically 2mL per 5mg vial, producing a 2.5mg/mL concentration. Use the free PSPeptides calculator for exact syringe units at any dose. Administer subcutaneously on an empty stomach — the GH response is significantly blunted by elevated blood glucose and free fatty acids, making fasted timing essential for optimal results.
Store the reconstituted compound at 2-8°C and use within 28 days of reconstitution (the bacteriostatic water preservation window). The GHRP-2 peptide is relatively stable when properly stored but should be protected from light and temperature fluctuations. The PSPeptides storage guide covers compound-specific handling requirements. GHRP-2’s short half-life (~30 minutes) means researchers should time administration to align with their GH measurement or research endpoint window.
The PSPeptides Quality and Support Standard
PSPeptides provides research-grade peptides at 99%+ purity verified through third-party HPLC testing with batch-specific Certificates of Analysis from independent laboratories. US-based manufacturing under domestic regulatory oversight. Same-day processing seven days a week including Sundays. Free shipping on every domestic order. Free international shipping to 30+ countries on orders over $150. Zero processing fees on Affirm, Afterpay, Zelle, cards, Apple Pay, and Google Pay. 24/7 customer support via live chat, email at [email protected], and phone/text at (551) 284-2670.
The free reconstitution and dosage calculator at pspeptides.com/peptide-calculator provides visual syringe diagrams and video tutorials for accurate preparation of every compound. The 5-star rating from thousands of verified customers confirms consistent quality and service. Complete supplies — bacteriostatic water ($19.99), EasyTouch insulin syringes, and alcohol prep pads — ship alongside research peptides in a single free checkout. PSPeptides provides the complete research peptide experience: verified compounds, essential supplies, preparation tools, educational resources, and around-the-clock human support.
The GH Secretagogue Selectivity Spectrum
Understanding the GHRP-2 peptide’s position in the GH secretagogue selectivity spectrum helps researchers choose the right compound. From most selective (cleanest) to least selective (broadest): Ipamorelin → GHRP-2 → GHRP-6 → Hexarelin. GHRP-2 occupies the middle ground — more potent than Ipamorelin but cleaner than GHRP-6. This moderate selectivity makes it the versatile choice for researchers who want stronger GH than Ipamorelin provides but fewer side effects than GHRP-6 produces.
The selectivity spectrum also reflects the tradeoff between GH amplitude and off-target effects that every GH secretagogue researcher must navigate. Its moderate position means it is never the “wrong” choice — it provides meaningful GH release without the extreme appetite stimulation of GHRP-6 or the potential desensitization risk of Hexarelin. For researchers beginning GH secretagogue research, pralmorelin is often the recommended starting compound because of this balanced profile.
Published Clinical Research Summary
GHRP-2 has an extensive published research base. Key studies include the Arvat et al. (1997) head-to-head GHRP comparison establishing GHRP-2 as the most potent standard GHRP. The Laferrère et al. (2005) Journal of Clinical Endocrinology & Metabolism study documenting GHRP-2’s appetite-stimulating effects in healthy humans. The multiple Japanese clinical validation studies establishing the pralmorelin stimulation test for GH deficiency diagnosis. And the Ghigo et al. (1997) characterization of GHRP-2’s HPA axis effects supporting its use in cortisol testing protocols.
This clinical research depth gives GHRP-2 a safety and characterization profile that newer, less-studied compounds cannot match. For researchers who value compound characterization — knowing the pharmacological profile, the dose-response relationships, the expected side effects, and the clinical validation history — pralmorelin provides the most thoroughly documented option in the GHRP class. Buy GHRP-2 at PSPeptides with 99%+ verified purity, free shipping, and same-day processing.
Complete Product Catalog at PSPeptides
Retatrutide $39.99-$119.99. Tirzepatide $54.99-$104.99. MOTS-C $69.99-$189.99. Epitalon $59.99-$129.99. GHK-Cu $29.99-$39.99. GLOW $69.99. KLOW $89.99. Semax $42.99. Selank $32.99. BPC-157 $49.99-$89.99. TB-500 $44.99-$79.99. GHRP-2. GHRP-6. Cagrilintide. Ipamorelin $39.99. CJC/Ipa Blend $65.99. Sermorelin $44.99-$79.99. Bacteriostatic water $19.99. All with free shipping, same-day processing, and zero checkout fees at pspeptides.com/shop.
Why Researchers Choose PSPeptides for GHRP-2
Pralmorelin at PSPeptides provides the potency advantage that serious GH researchers demand, backed by the quality verification, supply integration, and support infrastructure that makes research successful. 99%+ HPLC-verified purity ensures the labeled compound matches the actual content — critical when this compound’s value lies in its precise GH-stimulating potency. Batch-specific COAs from third-party laboratories verify every production lot. Bacteriostatic water ($19.99), EasyTouch syringes, and alcohol prep pads ship alongside GHRP-2 in a single free checkout.
The free reconstitution calculator supports GHRP-2 peptide preparation at any dose with visual syringe output. 24/7 support via live chat, email, phone, and text provides guidance for compound selection, reconstitution, and protocol questions at any hour. The 5-star rating from thousands of verified customers confirms that PSPeptides delivers the GHRP-2 peptide — and every product in the catalog — with the quality and service that GH research demands.
The GHRP-2 peptide at PSPeptides represents the pinnacle of GH secretagogue potency — the compound with the strongest published GH release, the only GHRP with regulatory approval (Japan), and the most thoroughly characterized safety profile in the class. For researchers who demand maximum GH amplitude from a verified-quality source with complete supplies, free shipping, same-day processing, and 24/7 support, pralmorelin at PSPeptides provides the optimal starting point. Begin your GHRP-2 peptide research at pspeptides.com.
Understanding ghrp-2 peptide is essential for researchers navigating this rapidly evolving field in 2026.
How GHRP-2 Compares to Other GH Secretagogues
Researchers selecting between GH secretagogues face a fundamental tradeoff between potency and selectivity. Pralmorelin occupies a well-defined position in this spectrum that makes it suitable for a broad range of research applications. Understanding where it fits relative to alternatives helps researchers design appropriate protocols and interpret results accurately.
Compared to Ipamorelin, the GHRP-2 peptide produces approximately 50–60% higher peak GH concentrations but also stimulates cortisol (typically 10–20% above baseline) and prolactin at higher doses. Ipamorelin produces minimal off-target hormone activation, making it preferred when clean GH measurement is the priority. Research published in the European Journal of Endocrinology confirmed that pralmorelin’s cortisol stimulation, while measurable, remains within clinically acceptable ranges in healthy subjects.
Compared to GHRP-6, pralmorelin produces similar GH amplitude but substantially less ghrelin-mediated appetite stimulation. GHRP-6 triggers significant hunger responses in most subjects — a practical limitation in research protocols requiring controlled feeding conditions. The GHRP-2 peptide’s moderate appetite effect makes it easier to standardize across subjects in multi-dose protocols.
Compared to Hexarelin, pralmorelin shows a more favorable desensitization profile. Hexarelin demonstrates receptor downregulation with continuous use more rapidly than other GHRPs, which limits its utility in longer-duration studies. The GHRP-2 peptide maintains more consistent GH responses over research periods of 4–8 weeks when administered 2–3 times daily, according to published dose-response studies.
| Compound | GH Potency | Cortisol Effect | Appetite Stimulation | Desensitization Risk |
|---|---|---|---|---|
| GHRP-2 (Pralmorelin) | High (40–60 ng/mL) | Moderate (+10–20%) | Moderate | Low-Moderate |
| Ipamorelin | Moderate (20–35 ng/mL) | Minimal | Minimal | Low |
| GHRP-6 | High (40–55 ng/mL) | Moderate | High | Low-Moderate |
| Hexarelin | Very High (50–70 ng/mL) | High | Moderate | High |
For most GH secretagogue research protocols, the GHRP-2 peptide represents the optimal balance point — delivering strong, reliable GH release with a well-characterized side effect profile and decades of published literature for result interpretation. Researchers new to GH secretagogue study typically begin with pralmorelin before branching into more specialized compounds based on their specific research questions.
Frequently Asked Questions
What is GHRP-2 (pralmorelin)?
GHRP-2 (pralmorelin) is a synthetic hexapeptide GH secretagogue that produces the strongest GH pulse among common GHRPs. It is the only GHRP approved by any regulatory agency (Japan, for GH deficiency diagnosis).
What is the standard GHRP-2 dosage?
100-300mcg subcutaneously, 2-3 times daily on an empty stomach. The free PSPeptides calculator provides exact syringe units for any dose.
Does PSPeptides sell GHRP-2?
Yes. Research-grade GHRP-2 at 99%+ HPLC purity with batch-specific COAs. Free shipping, same-day processing including Sundays, Affirm/Afterpay at zero fees.
How does GHRP-2 compare to Ipamorelin?
GHRP-2 produces stronger GH pulses but has more side effects (cortisol, prolactin, appetite). Ipamorelin is cleaner but less potent. PSPeptides carries both.
All PSPeptides products are sold exclusively for research and laboratory use.